Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients

The relationship between the nasopharyngeal virus load, IgA and IgG antibodies to both the S1-RBD-protein and the N-protein, as well as the neutralizing activity (NAbs) against SARS-CoV-2 in the blood of moderately afflicted COVID-19 patients, needs further longitudinal investigation. Several new se...

Full description

Bibliographic Details
Main Authors: Bertram Flehmig, Michael Schindler, Natalia Ruetalo, Ramona Businger, Manfred Bayer, Angelika Haage, Thomas Kirchner, Karin Klingel, Andrea Normann, Lutz Pridzun, Despina Tougianidou, Michael B. Ranke
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/12/1357
_version_ 1797546640663379968
author Bertram Flehmig
Michael Schindler
Natalia Ruetalo
Ramona Businger
Manfred Bayer
Angelika Haage
Thomas Kirchner
Karin Klingel
Andrea Normann
Lutz Pridzun
Despina Tougianidou
Michael B. Ranke
author_facet Bertram Flehmig
Michael Schindler
Natalia Ruetalo
Ramona Businger
Manfred Bayer
Angelika Haage
Thomas Kirchner
Karin Klingel
Andrea Normann
Lutz Pridzun
Despina Tougianidou
Michael B. Ranke
author_sort Bertram Flehmig
collection DOAJ
description The relationship between the nasopharyngeal virus load, IgA and IgG antibodies to both the S1-RBD-protein and the N-protein, as well as the neutralizing activity (NAbs) against SARS-CoV-2 in the blood of moderately afflicted COVID-19 patients, needs further longitudinal investigation. Several new serological methods to examine these parameters were developed, validated and applied in three patients of a family which underwent an ambulatory course of COVID-19 for six months. The virus load had almost completely disappeared after about four weeks. Serum IgA levels to the S1-RBD-protein and, to a lesser extent, to the N-protein, peaked about three weeks after clinical disease onset but declined soon thereafter. IgG levels rose continuously, reaching a plateau at approximately six weeks, and stayed elevated over the observation period. Virus-neutralizing activity reached a peak about 4 weeks after disease onset but dropped slowly. The longitudinal associations of virus neutralization and the serological immune response suggest immunity in patients even after a mild clinical course of COVID-19.
first_indexed 2024-03-10T14:32:34Z
format Article
id doaj.art-f3f76e2ee5e642d5af3dde3fd544e4a3
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T14:32:34Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-f3f76e2ee5e642d5af3dde3fd544e4a32023-11-20T22:32:00ZengMDPI AGViruses1999-49152020-11-011212135710.3390/v12121357Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 PatientsBertram Flehmig0Michael Schindler1Natalia Ruetalo2Ramona Businger3Manfred Bayer4Angelika Haage5Thomas Kirchner6Karin Klingel7Andrea Normann8Lutz Pridzun9Despina Tougianidou10Michael B. Ranke11Paediatric Endocrinolgy, University Children’s Hospital, Hoppe-Seyler-Str. 1, 72076 Tuebingen, GermanyInstitute for Medical Virology and Epidemiology, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, 72076 Tuebingen, GermanyInstitute for Medical Virology and Epidemiology, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, 72076 Tuebingen, GermanyInstitute for Medical Virology and Epidemiology, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, 72076 Tuebingen, Germany4base Lab AG Advanced Molecular Analysis, Aspenhaustr. 25, 72770 Reutlingen, GermanyMediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH, Aspenhaustr. 25, 72770 Reutlingen, GermanyPediatric Practice, Kapuzinerberg 17, 71263 Weil der Stadt, GermanyInstitute for Pathology and Neuropathology, University Hospital Tuebingen, Liebermeisterstr. 8, 72076 Tuebingen, GermanyMediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH, Aspenhaustr. 25, 72770 Reutlingen, GermanyMediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH, Aspenhaustr. 25, 72770 Reutlingen, Germany4base Lab AG Advanced Molecular Analysis, Aspenhaustr. 25, 72770 Reutlingen, GermanyPaediatric Endocrinolgy, University Children’s Hospital, Hoppe-Seyler-Str. 1, 72076 Tuebingen, GermanyThe relationship between the nasopharyngeal virus load, IgA and IgG antibodies to both the S1-RBD-protein and the N-protein, as well as the neutralizing activity (NAbs) against SARS-CoV-2 in the blood of moderately afflicted COVID-19 patients, needs further longitudinal investigation. Several new serological methods to examine these parameters were developed, validated and applied in three patients of a family which underwent an ambulatory course of COVID-19 for six months. The virus load had almost completely disappeared after about four weeks. Serum IgA levels to the S1-RBD-protein and, to a lesser extent, to the N-protein, peaked about three weeks after clinical disease onset but declined soon thereafter. IgG levels rose continuously, reaching a plateau at approximately six weeks, and stayed elevated over the observation period. Virus-neutralizing activity reached a peak about 4 weeks after disease onset but dropped slowly. The longitudinal associations of virus neutralization and the serological immune response suggest immunity in patients even after a mild clinical course of COVID-19.https://www.mdpi.com/1999-4915/12/12/1357COVID-19SARS-CoV-2 RT-qPCRanti-SARS-CoV-2 antibodiesSARS-CoV-2 S1-RDB proteinSARS-CoV-2 N-proteinSARS-CoV-2 neutralizing activity
spellingShingle Bertram Flehmig
Michael Schindler
Natalia Ruetalo
Ramona Businger
Manfred Bayer
Angelika Haage
Thomas Kirchner
Karin Klingel
Andrea Normann
Lutz Pridzun
Despina Tougianidou
Michael B. Ranke
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
Viruses
COVID-19
SARS-CoV-2 RT-qPCR
anti-SARS-CoV-2 antibodies
SARS-CoV-2 S1-RDB protein
SARS-CoV-2 N-protein
SARS-CoV-2 neutralizing activity
title Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
title_full Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
title_fullStr Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
title_full_unstemmed Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
title_short Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
title_sort persisting neutralizing activity to sars cov 2 over months in sera of covid 19 patients
topic COVID-19
SARS-CoV-2 RT-qPCR
anti-SARS-CoV-2 antibodies
SARS-CoV-2 S1-RDB protein
SARS-CoV-2 N-protein
SARS-CoV-2 neutralizing activity
url https://www.mdpi.com/1999-4915/12/12/1357
work_keys_str_mv AT bertramflehmig persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT michaelschindler persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT nataliaruetalo persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT ramonabusinger persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT manfredbayer persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT angelikahaage persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT thomaskirchner persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT karinklingel persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT andreanormann persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT lutzpridzun persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT despinatougianidou persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients
AT michaelbranke persistingneutralizingactivitytosarscov2overmonthsinseraofcovid19patients